Neither plasma coenzyme Q10 concentration, nor its decline during pravastatin therapy, is linked to recurrent cardiovascular disease events: A prospective case–control study from the LIPID study
Roland Stocker, Christine Pollicino, Craig A. Gay, Paul Nestel, David Colquhoun, Malcolm Whiting, Andrew Tonkin, David Sullivan, John SimesVolume:
187
Year:
2006
Language:
english
DOI:
10.1016/j.atherosclerosis.2005.09.004
File:
PDF, 128 KB
english, 2006